Cargando…
Hydroxychloroquine/mycophenolate-mofetil/tacrolimus: Delayed viral clearance, gastrointestinal adverse reactions and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298934/ http://dx.doi.org/10.1007/s40278-021-99499-7 |
Ejemplares similares
-
Mycophenolate-mofetil/prednisone/tacrolimus: Infections: case report
Publicado: (2020) -
Mycophenolate mofetil/tacrolimus: Cutaneous leishmaniasis: case report
Publicado: (2021) -
Mycophenolate-mofetil/tacrolimus: COVID-19: case report
Publicado: (2022) -
Hydroxychloroquine/methylprednisolone/nafamostat: Delayed viral clearance and off label use: case report
Publicado: (2021) -
Mycophenolate mofetil/tacrolimus: COVID-19 infection: case report
Publicado: (2021)